My read on the tweet is its more about CSIRO and what it offers enterprise than Admedus.
Is there still any collaboration? There has been no mention of it from the company in the last 4 years.
This was very old and was looking at using the product as pottential scaffolding for stem cell delivery. Nothing has come of it to date.
CSIRO tweet, page-24
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $363.6M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $158.2K | 8.532K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $18.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.60 | 113 | 2 |
View Market Depth
| Last trade - 15.59pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |